Annual report admits to disappointments. 'Current marketing' of 'bionic leg' is actually a study of patients in rehab centres (given for free?) that hasn't started yet
. Ossur now fully in control of the decision-making about when/how/whether to launch the product -- it may never happen
. Reading the fine print, this leg is only 'motorized' -- like well-established and less costly competitors. While there are dreams of involving 'bionic' or non-mechanical control mechanisms, this is only in version 2 or even later versions -- still very much in early clinical trials. The odds of these good ideas making it out of clinical trials?
. Maybe we should hand last year's VHB press releases over to Gomery, too.